My Selling Point Of E-64

A total of 347 (14.1%) DEC isolates were collected, and EAEC (217, 62.5%) was the most prevalent pathotype identified, followed by ETEC (62, 17.9%), EPEC (52, 15.0%), STEC (14, 4.0%) and EIEC (1, 0.3%). One (0.3%) strain was astA+, aggR+ and elt+. Among the STEC stains, stx2+ strains accounted for 78.6%, and none was stx1+ and stx2+ (Table?2). Among the 347 isolates, 142 (40.9%) were typable for their O antigens, 6 (1.7%) were defined as ��rough��, and the O antigen types of 199 (57.3%) isolates could not be determined. A total of 35.5% (77/217), 76.7% (43/62), 38.5% (20/52) and 14.3% (2/14) of EAEC, ETEC, EPEC and STEC isolates were O click here antigen typable, respectively. The dominant O serogroups were O45 (23 isolates, 6.6%), O6 (22, 6.3%) and O25 (14, 4.0%), and the others belonged to 24 serogroups. The EAEC, ETEC and EPEC isolates belonged to 23, 11 and 9 serogroups, respectively. O45, O148 and O45 were the predominant serogroups of EAEC, ETEC and EPEC isolates, respectively. One STEC isolate was identified as O157:H7 (Table?2). A total of 340 isolates (seven isolates died) were analysed and found to have 166 different sequence types (ST), of which 78 were novel types. The most prevalent genotypes were ST complex (STC) 10 (87, 25.6%), ST38 (11, 3.2%) and ST226 (10, 2.9%). STC10 includes ST10, ST48, ST218 and 20 other types, and ST10 is the predominant type among E-64 STC10 isolates (25, 28.7%). The EAEC, EPEC and ETEC isolates belonged to 114, 40 and 24 STs, and STC10 accounted for 19.3% (41/212), 21.2% (11/52) and 55.7% (34/61) of isolates, respectively. The data are presented in Fig.?1(a). A total of 59.1% (13/22) of O6 isolates, 42.9% (6/14) of O25 isolates, 80.0% (8/10) of O148 isolates R428 and 75.0% (6/8) of O159 isolates belonged to ST48, ST1491, ST94 and ST218, respectively. Two isolates were EAEC-O104:H4-ST678. Of the 342 isolates (five isolates died), 91.8% were resistant to ampicillin; 52.3�C57.6% were resistant to cefazolin, tetracycline, ampicillin-sulbactam and trimethoprim-sulphamethoxazole; and